DNLI's DNL343 fails to achieve the primary and secondary endpoints, as observed from an analysis of Regimen G of the phase II ...

Jeffrey Jenkins, a 38-year-old aspiring surgeon, dedicated his life to medicine - but his world came crashing down with a ...

In studies by Massachusetts General Hospital, the AbbVie-Calico collaborative drug and Denali Therapeutics' own drug failed to meet endpoints for treating amyotrophic lateral sclerosis, more widely ...

Primary endpoint of overall function (ALSFRS-R) and survival, and key secondary endpoints of muscle strength and respiratory function, were not ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully ...

This confirmation follows the Company's successful efforts to improve its balance sheet by raising new equity and reducing outstanding liabilities. As a result, NeuroSense shareholders' equity now ...

Magnesium threonate has been shown in some animal studies to enhance cognitive function by raising magnesium ions in the ...

Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in a Phase III STEER study (NCT05089656) ...

Neuron, Cell Press's prestigious neuroscience journal, is publishing a special issue on aging research on January 8, 2025. The collection of reviews ...

Aging involves gradual functional decline across various biological systems, including impaired cellular mechanisms such as ...

"The EDSS has a number of limitations and may also measure changes that are not related to MS, such as older age and multiple ...

A year ago, Terry Bott, 69, was diagnosed with motor neurone disease and told he had only a short time to live. Eight months later, having prepared for his death, he learned he had not got MND ...